Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
Status:
Completed
Trial end date:
2015-05-30
Target enrollment:
Participant gender:
Summary
The Department of Counseling, Educational Psychology, and Special Education and the
Department of Psychiatry at Michigan State University have coordinated efforts to provide a
diagnostic and treatment investigation for children, ages seven to eighteen, with Selective
Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment
of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective
mutism symptomology.